To start page

2012-2-23	+/-%	Buy	Sell	Latest	Volume	Turnover (SEK)
NVP	-7.04%	18.50	18.60	18.50	65 845	1 231 429.10

Home
About NeuroVive
Research & Development
Investors
Contact

About NeuroVive

In brief
Board of Directors
Management Team
Advisory Board
Corporate Governance
Partnerships
Career

Start / About NeuroVive / Corporate Governance

Corporate Governance

Eleonor Åsander Frostner

Responsible editor Eleonor Åsander Frostner eleonor.asander@neurovive.com Last updated: 2011-06-23

About NeuroVive
Research & Development
Investors
Contact

NeuroVive Pharmaceutical AB (publ), Biomedical Center, BMC D10, SE-221 84 Lund, Sweden

Tel: +46 (0)46 288 01 10 | Fax: +46 (0)46 888 83 48 | info@neurovive.com | Legal & Privacy